Grifols shifts toward value diagnostics
By Ion Jauregui ā Analyst at ActivTradesStrategic break with QuidelOrtho and new stage in diagnosticsThe Spanish company Grifols has ended its more than four-decade alliance with QuidelOrtho for the production of antigens, in a move that marks a turning point in its diagnostics strategy. As part of the agreement, it will receive 65 million dollars…
